Intraductal Papillary Mucinous Neoplasm With Malignant Change

Intraductal Papillary Mucinous Neoplasm (IPMN) With Malignant Change: Prospective Study to Assess Diagnostic Performance of CT and Magnetic Resonance Imaging (MR) According to International Consensus Guidelines 2012

Purpose:

To investigate diagnostic performance of CT and MR in intraductal papillary mucinous neoplasm with malignant change according to international consensus guidelines 2012.

Hypothesis: According to 2012 consensus guidelines, enhanced solid component and main pancreatic duct size of larger than 10 mm will be significant.

1. Purpose

   • To investigate diagnostic performance of CT and MR in intraductal papillary mucinous neoplasm with malignant change according to international consensus guidelines 2012

2. Enroll criteria

   • Patient who is suspected to have pancreas IPMN on imaging
   • Interval between imaging study and surgery is less than 2 months
   • Who is scheduled for surgery due to IPMN

Inclusion Criteria:

• Patients who is suspected to have IPMN by imaging study or clinician
• Time interval between imaging study and surgery less than 2 months

Exclusion Criteria:

• Patients who have pathology results not by surgery
• Who is less than 20 years old
• Who cannot voluntarily agree study design